Health Care & Life Sciences » Biotechnology | Dynavax Technologies Corp.

Dynavax Technologies Corp. | Ownership

Companies that own Dynavax Technologies Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
SSgA Funds Management, Inc.
5,467,391
8.73%
977,321
0.01%
06/30/2018
BlackRock Fund Advisors
3,701,447
5.91%
149,335
0%
06/30/2018
Franklin Advisers, Inc.
2,870,330
4.58%
206,900
0.03%
06/30/2018
The Vanguard Group, Inc.
2,735,918
4.37%
149,915
0%
06/30/2018
HealthCor Management LP
2,531,107
4.04%
1,212,495
1.01%
06/30/2018
Senvest Management LLC
2,336,089
3.73%
806,102
2.06%
06/30/2018
Eagle Asset Management, Inc.
2,298,658
3.67%
2,298,658
0.15%
06/30/2018
PointState Capital LP
1,888,500
3.02%
1,888,500
0.31%
06/30/2018
D. E. Shaw & Co. LP
1,806,960
2.89%
160,677
0.04%
06/30/2018
Federated Global Investment Management Corp.
1,657,775
2.65%
-762,625
0.16%
06/30/2018

About Dynavax Technologies

View Profile
Address
2929 Seventh Street
Berkeley California 94710
United States
Employees -
Website http://www.dynavax.com
Updated 07/08/2019
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.